##  [Novartis Kisqali® demonstrates nearly five years median overall survival in metastatic breast cancer](/us-en/news/media-releases/novartis-kisqali-demonstrates-nearly-five-years-median-overall-survival-metastatic-breast-cancer-0 "Novartis Kisqali® demonstrates nearly five years median overall survival in metastatic breast cancer") 

  Dec 09, 2020